ASX
Firebrick Pharma Limited
FRE:ASX•Healthcare
Sensitive ASX Announcement
Nasodine Phase 3 Clinical Trial Surpasses 80% Recruitment
Published: 31/05/23, 09:01am (AEST)•2 pages